Free shipping on all orders over $ 500

TPX-0131

Cat. No. M14147

All AbMole products are for research use only, cannot be used for human consumption.

TPX-0131  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

The CNS-penetrant ALK kinase inhibitor TPX-0131 was more potent in vitro against WT-ALK and many ALK resistance mutations than all five approved ALK inhibitors.

Chemical Information
Molecular Weight 447.41
Formula C21H20F3N5O3
CAS Number 2648641-36-3
Solubility (25°C) DMSO : 25 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related ALK Products
F-1

F-1 is a potent ALK and ROS1 dual inhibitor, suppresses phospho-ALK and its relative downstream signaling pathways, with IC50 values of 2.1 nM, 2.3 nM, 1.3 nM and 3.9 nM for ALKWT, ROS1WT, ALKL1196M and ALKG1202R, respectively.

TL13-22 

TL13-22 is a negative control for TL13-12 and a potent ALK inhibitor with an IC50 of 0.54 nM.

TL13-110 

TL13-110 is a negative control for TL13-112 and a potent ALK inhibitor with an IC50 of 0.34 nM.

ALK inhibitor 2 

ALK inhibitor 2 is a potent pyrimidin ALK inhibitor.

NVL-655 TFA

NVL-655 (ALK-IN-27) TFA is a novel, brain-permeable, selective ALK inhibitor with antitumor activity. For Ba/F3 CLIP1-LTK cells, NVL-655 (ALK-IN-27) TFA has an IC50 of 2.7 nM. It can be used in studies related to ALK-positive non-small cell lung cancer (NSCLC).

  Catalog
Abmole Inhibitor Catalog




Keywords: TPX-0131 supplier, ALK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.